Literature DB >> 19885027

Quantitative Structure Activity Relationship between Diazabicyclo[4.2.0]octanes Derivatives and Nicotinic Acetylcholine Receptor Agonists.

Eun Ae Kim1, Kyoung Chul Jung, Uy Dong Sohn, Chaeuk Im.   

Abstract

Three dimensional quantitative structure activity relationship between diazabicyclo[4.2.0]octanes and nicotinic acetylcholine receptor (halpha4beta2 and halpha3beta4) agonists was studied using comparative molecular field analysis (CoMFA) and comparative molecular similarity indices analysis (CoMSIA). From 11 CoMFA and CoMSIA models, CoMSIA with steric and electrostatic fields gave the best predictive models (q(2)=0.926 and 0.945, r(2) (ncv)=0.983 and 0.988). This study can be used to develop potent halpha4beta2 receptor agonists with low activity on halpha3beta4 subtype.

Entities:  

Keywords:  CoMFA; CoMSIA; Diazabicyclo[4.2.0]octanes; Nicotinic acetylcholine receptors (nAChRs)

Year:  2009        PMID: 19885027      PMCID: PMC2766720          DOI: 10.4196/kjpp.2009.13.1.55

Source DB:  PubMed          Journal:  Korean J Physiol Pharmacol        ISSN: 1226-4512            Impact factor:   2.016


  16 in total

1.  Chemical-scale studies on the role of a conserved aspartate in preorganizing the agonist binding site of the nicotinic acetylcholine receptor.

Authors:  Amanda L Cashin; Michael M Torrice; Kathryn A McMenimen; Henry A Lester; Dennis A Dougherty
Journal:  Biochemistry       Date:  2007-01-23       Impact factor: 3.162

Review 2.  Targeting the alpha9alpha10 nicotinic acetylcholine receptor to treat severe pain.

Authors:  Michelle Vincler; J Michael McIntosh
Journal:  Expert Opin Ther Targets       Date:  2007-07       Impact factor: 6.902

3.  Roles of accessory subunits in alpha4beta2(*) nicotinic receptors.

Authors:  Alexandre Kuryatov; Jennifer Onksen; Jon Lindstrom
Journal:  Mol Pharmacol       Date:  2008-04-01       Impact factor: 4.436

4.  Synthesis and structure-activity relationships of 3,8-diazabicyclo[4.2.0]octane ligands, potent nicotinic acetylcholine receptor agonists.

Authors:  Jennifer M Frost; William H Bunnelle; Karin R Tietje; David J Anderson; Lynne E Rueter; Peter Curzon; Carol S Surowy; Jianquo Ji; Jerome F Daanen; Kathy L Kohlhaas; Michael J Buckley; Rodger F Henry; Tino Dyhring; Philip K Ahring; Michael D Meyer
Journal:  J Med Chem       Date:  2006-12-28       Impact factor: 7.446

5.  Evidence for a complex influence of nicotinic acetylcholine receptors on hippocampal serotonin release.

Authors:  P J Kenny; S E File; M J Neal
Journal:  J Neurochem       Date:  2000-12       Impact factor: 5.372

Review 6.  The subtypes of nicotinic acetylcholine receptors on dopaminergic terminals of mouse striatum.

Authors:  Sharon R Grady; Outi Salminen; Duncan C Laverty; Paul Whiteaker; J Michael McIntosh; Allan C Collins; Michael J Marks
Journal:  Biochem Pharmacol       Date:  2007-07-27       Impact factor: 5.858

7.  Expression of alpha-7 and alpha-4 nicotinic acetylcholine receptors by GABAergic neurons of rostral ventral medulla and caudal pons.

Authors:  Ozra Dehkordi; Richard M Millis; Gary C Dennis; Ehsan Jazini; Carlos Williams; Dulara Hussain; Anna Jayam-Trouth
Journal:  Brain Res       Date:  2007-09-21       Impact factor: 3.252

Review 8.  Efficacy and safety of varenicline for smoking cessation.

Authors:  J Taylor Hays; Jon O Ebbert; Amit Sood
Journal:  Am J Med       Date:  2008-04       Impact factor: 4.965

9.  Crucial role of alpha4 and alpha6 nicotinic acetylcholine receptor subunits from ventral tegmental area in systemic nicotine self-administration.

Authors:  S Pons; L Fattore; G Cossu; S Tolu; E Porcu; J M McIntosh; J P Changeux; U Maskos; W Fratta
Journal:  J Neurosci       Date:  2008-11-19       Impact factor: 6.167

10.  On the nature of partial agonism in the nicotinic receptor superfamily.

Authors:  Remigijus Lape; David Colquhoun; Lucia G Sivilotti
Journal:  Nature       Date:  2008-07-16       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.